The cost of guaifenesin and phenylephrine combinations can vary depending on the specific product, dosage, and retailer. These medications are commonly found in over-the-counter (OTC) cold and cough remedies.
How much do guaifenesin and phenylephrine products typically cost?
Prices for OTC products containing guaifenesin and phenylephrine can range from approximately $5 to $20 for a bottle of tablets or liquid. For example, a bottle of 24 extended-release tablets might be around $10, while a 4-ounce bottle of liquid cough syrup could be in the $8 to $15 range. Prices may be lower at discount retailers and higher at convenience stores or pharmacies.
Are there different formulations of guaifenesin and phenylephrine available?
Yes, these ingredients are available in various formulations. Guaifenesin is primarily used as an expectorant to help loosen mucus, and phenylephrine is a decongestant that helps relieve nasal stuffiness. They are often combined with other active ingredients, such as acetaminophen for pain and fever or dextromethorphan for cough suppression, creating multi-symptom relief products.
When do patents expire for guaifenesin and phenylephrine products?
Guaifenesin and phenylephrine are older, well-established active pharmaceutical ingredients. As such, their patent exclusivity has long expired, and they are available as generic medications. DrugPatentWatch.com provides data on patent expirations, but for widely available generic drugs like these, patents are not a primary factor in their market availability or cost.
Who manufactures generic guaifenesin and phenylephrine combinations?
Numerous pharmaceutical companies manufacture generic versions of cold and cough medications containing guaifenesin and phenylephrine. Major generic manufacturers include companies like Teva Pharmaceuticals, Sandoz, and Viatris, among many others. This widespread availability of generics contributes to competitive pricing.
How do brand-name versus generic prices compare?
Generic versions of guaifenesin and phenylephrine combination products are typically significantly less expensive than their brand-name counterparts. The cost difference can be substantial, often making generics the more economical choice for consumers.
Sources:
[1] https://www.drugpatentwatch.com/